Prognostic effect of weight loss prior tochemotherapy in cancer patients

The American Journal of Medicine - Tập 69 Số 4 - Trang 491-497 - 1980
William D. DeWys1, Colin B. Begg1, Philip T. Lavin1, Pierre R. Band1, John M. Bennett1, Joseph R. Bertino1, Martin H. Cohen1, Harold O. Douglass1, Paul F. Engstrom1, Ediz Z. Ezdinli1, John Horton1, Gerhard J. Johnson1, Charles G. Moertel1, Martin M. Oken1, Charles P. Perlia1, Charles Rosenbaum1, Murray N. Silverstein1, Roland T. Skeel1, Robert W. Sponzo1, Douglass C. Tormey1
1National Cancer Institute, NationalInstitutes of Health, and the Department of Health and Human Services, Bethesda, Maryland 20205, USA

Tóm tắt

Từ khóa


Tài liệu tham khảo

Zelen, 1973, Keynote address on biostatistics and data retrieval, Cancer Chemother Rep, 4, 31

Copeland, 1977, Nutrition as an adjuvant to cancer treatment in the adult, Cancer Res, 37, 2451

Lanzotti, 1975, Cancer chemotherapeutic response and intravenous hyperalimentation, Cancer Chemother Rep, 59, 437

Byar, 1978, Results of a E.O.R.T.C. randomized trial of cyclophosphamide and radiotherapy in inoperable lung cancer: Prognostic factors and treatment results, Eur J Cancer, 14, 919, 10.1016/0014-2964(78)90018-X

Lanzotti, 1977, Survival with inoperable lung cancer-integration of prognostic variables based on simple clinical criteria, Cancer, 39, 303, 10.1002/1097-0142(197701)39:1<303::AID-CNCR2820390147>3.0.CO;2-U

Tubiana, 1971, Prognostic factors in 454 cases of Hodgkin's disease, Cancer Res, 31, 1801

Skeel, 1980, Cyclophosphamide, cytosine arabinoside and methotrexate versus cytosine arabinoside and thioguanine for acute non-lymphocytic leukemia in adults, Cancer, 45, 224, 10.1002/1097-0142(19800115)45:2<224::AID-CNCR2820450205>3.0.CO;2-D

Perlia, 1976, Adriamycin and cytoxan in the treatment in inoperable lung cancer (abstract), 17, 27

Carbone, 1977, Chemotherapy of disseminated breast cancer. Current status and prospects, Cancer, 39, 2916, 10.1002/1097-0142(197706)39:6<2916::AID-CNCR2820390678>3.0.CO;2-Z

Band, 1977, Induction chemotherapy and maintenance chemo-hormonotherapy in metastatic breast cancer (abstract), 18, 228

DeWys, 1978, Comparison of adriamycin (ADRIA) and 5-fluorouracil (5FU) in advanced prostatic cancer (abstract), 19, 331

Douglass, 1978, Cancer, 42, 2538, 10.1002/1097-0142(197812)42:6<2538::AID-CNCR2820420606>3.0.CO;2-A

Lavin P, Mittelman A, Douglass H Jr, Engstrom P, Klaasen D: Survival and response to chemotherapy of colorectal adenocarcinoma. Cancer (in press).

Rosenbaum, 1977, Treatment of advanced soft tissue sarcoma, 18, 287

Bennett, 1977, Chemotherapy of non-Hodgkin's lymphomas: Eastern Cooperative Oncology Group Experience, Cancer Treat Rep, 61, 1079

Ezdinli, 1978, Chemotherapy of prognostically favorable non-Hodgkin's lymphomas (abstract), 19, 310

Ezdinli, 1979, Eastern Cooperative Oncology Group experience with the Rappaport classification of non-Hodgkin's lymphomas, Cancer, 43, 544, 10.1002/1097-0142(197902)43:2<544::AID-CNCR2820430221>3.0.CO;2-P

Johnson, 1978, Cyclophosphamide (C), vincristine (V), and prednisone (P) plus adriamycin (A), bleomycin (B) or BCNU: a prospective clin ical trial in unfavorable diffuse non-Hodgkin's lymphoma (NHL) (abstract), 19, 395

Johnson, 1979, The value of adriamycin and of mid-cycle treatment in multidrug therapy of unfavorable histology non-Hodgkin's lymphoma (abstract), 20, 196

Oken, 1979, Non-Hodgkin's lymphoma (NHL): effect of histologic subtype on toxicity and response to chemother apy, 20, 376

Moertel, 1979, Chemotherapy of gastric and pancreatic carcinoma—A controlled evaluation of combinations of 5-fluorouracil with nitrosoureas and “lactones”, Surgery, 85, 509

Mantel, 1966, Evaluation of survival data and two new rank order statistics arising in its consideration, Cancer Chemother Rep, 50, 163

Kaplan, 1958, Nonparametric estimation from incomplete observations, J Am Stat Assoc, 53, 457, 10.1080/01621459.1958.10501452

DeWys, 1979, Principles of nutritional care of the cancer patient

DeWys, 1979, Anorexia as a general effect of cancer, Cancer, 43, 2013, 10.1002/1097-0142(197905)43:5+<2013::AID-CNCR2820430709>3.0.CO;2-Z

Lundholm, 1976, Skeletal muscle metabolism in patients with malignant tumor, Eur J Cancer, 12, 465, 10.1016/0014-2964(76)90036-0

Warnold, 1978, Energy balance and body composition in cancer patients, Cancer Res, 38, 1801

Terepka, 1956, Metabolic observations during forced feeding of patients with cancer, Am J Med, 20, 225, 10.1016/0002-9343(56)90193-0

DeWys, 1975, Abnormalities of taste sensation in cancer patients, Cancer, 36, 1888, 10.1002/1097-0142(197511)36:5<1888::AID-CNCR2820360546>3.0.CO;2-Y

Fenniger, 1954, Energy and nitrogen metabolism in cancer, Adv Cancer Res, 2, 229, 10.1016/S0065-230X(08)60496-0

Brozek, 1963, Densitometric analysis of body composition: Revision of some quantitative assumptions, Ann NY Acad Sci, 110, 113, 10.1111/j.1749-6632.1963.tb17079.x

Henderson, 1969, Treatment of acute leukemia, Semin Hematol, 6, 271

DeWys, 1972, A quantitative model for the study of the growth and treatment of a tumor and its metastases with correlation between proliferative state andsensitivity to cyclophosphamide, Cancer Res, 32, 367

DeWys, 1972, Studies correlating the growth rate of a tumor and its metastases and providing evidence for tumor related systemic growth-retarding factors, Cancer Res, 32, 376

Frindell, 1967, Kinetics of cell proliferation of an experimental tumor, Cancer Res, 27, 1122

Valeriote, 1967, Comparison of the sensitivity of hematopoietic colony-forming cells in different proliferative states to vinblastine, J Natl Cancer Inst, 38, 393

Bruce, 1967, Comparison of the sensitivity of hematopoietic colony-forming cells in different proliferative states to 5-fluorouracil, J Natl Cancer Inst, 38, 401

Carbone, 1971, Report of the committee on Hodgkin's disease staging classification, Cancer Res, 31, 1860